Arkolith/Insider Trading/NKTR/Form 4

Wilson Mark Andrew

Chief Legal OfficerNEKTAR THERAPEUTICS (NKTR) · full profile →Form 4 · filed Nov 25, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$34K
Net Open-Market Flow
-$34K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 25, 2025Sell(S)630$54.28$34K22K
Nov 21, 2025Grant(A)2K—$022K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 21, 2025Grant(A)3K—$03K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-297852) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML